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Aberrant epigenetic methylation is linked to the onset and progression of cancer. In this issue of Chemistry &
Biology, Furst and Barton (2015) describe a sensitive electrochemical assay that can detect hyperactive
epigenetic methylation in tumor tissue.Since the initial provocative evidence that
DNA acts as a wire to facilitate electron
transfer between two redox-active inter-
calators, Jacqueline Barton and her co-
workers have delineated the fundamental
features of DNA-mediated charge trans-
port and illustrated how these features
may be used by nature (Genereux and
Barton, 2010; Grodick et al., 2015). In
addition, the Barton laboratory has devel-
oped many practical applications that
exploit the ‘‘wire-like’’ behavior of DNA
(Boon et al., 2003). In this issue, Furst
and Barton (2015) show that a DNA
charge transport based sensor may be
used as a new diagnostic tool for identi-
fying aberrant epigenetic markers associ-
ated with carcinogenic transformation.
Epigenetics encompasses a range of
cellular mechanisms that modulate tran-
scription at the level of individual genes.
Analogously to adjusting the bass or tre-
ble frequencies on a stereo, epigenetic
processes can facilitate biological com-
plexity by allowing one gene to be muted
or silenced while another may be ampli-
fied. These mechanisms, such as DNA
methylation and histone modification, do
not alter the primary sequence of the
DNA bases, but produce potentially heri-
table changes to the phenotypic expres-
sion of the genome. The epigenetic addi-
tion of methyl groups to the 5-position of
cytosine bases in a DNA sequence results
in a gradual silencing of the target gene.
Both hypomethylation and hypermethyla-
tion of oncogenes and of tumor suppres-
sor genes, respectively, may lead to
cancer. Maintenance of the correct
methylation patterns in the genome is
crucial as evidenced by the link between
anomalous methylation events and early
stages of cancer cell development (Baylin
and Herman, 2000).
Currently used methods for detecting
abnormal methylation activity suffer from810 Chemistry & Biology 22, July 23, 2015 ª2a number of flaws that make them unsuit-
able for clinical diagnostics. Many groups
have attempted to use the expression
levels of the predominant human DNA
methylating enzyme DNMT1 as a marker
of methylation status; however, these
measurements have not typically corre-
lated well with cellular methylation ability
because total protein does not account
for inherent enzyme activity. The most
sensitive and reliable method directly
tracks the activity of DNMT1, a difficult
and time-consuming process that uses
radiolabeled S-adenosylmethionine as
the methyl donor. Alternatively, methyl-
ation sites in the genome can be mapped
as a proxymeasure of methylation activity
in a cell. One such method uses DNA
digestion by methylation-sensitive re-
striction endonucleases, followed by
DNA detection; however, this analysis is
blind to regions of the genome that do
not have restriction sites. Bisulfite se-
quencing is unaffected by this bias but is
typically cost-limited in scope and there-
fore ill-suited to analyze the global
genomic methylation behavior of cells
(Fraga and Esteller, 2002). Notably,
methods that map methylation sites in
genomic DNA produce only a single,
static picture of cellular DNA methylation
and may not reflect early upticks in
methylation activity.
In this issue, Furst and Barton (2015)
demonstrate a simple and sensitive
method for monitoring aberrant DNMT1
methylation activity in tissue samples
(Muren and Barton, 2013; Furst et al.,
2014a). Key features of the assay are the
use of a two-electrode system coupled
with a catalytic redox cycle that amplifies
the electrochemical signals. In this sys-
tem, DNA-mediated charge transport is
detected by reduction of the redox inter-
calator methylene blue (MB) to leuco-
methylene blue (LB); LB in turn reduces015 Elsevier Ltd All rights reservedferricyanide to ferrocyanide, reoxidizing
itself back to MB. The DNA-mediated sig-
nals are detected at the second electrode
by current produced upon re-oxidation of
ferrocyanide (Furst et al., 2014b). The
duplex DNA acts as an antenna that trans-
mits the electric signal between the elec-
trodes, and therefore the amount of signal
generated is directly related to the
amount of intact duplex DNA. Digestion
of the immobilized DNA ‘‘antennae’’ by
a restriction enzyme short circuits the
device and results in loss of signal
(Figure 1A). DNA methylation by DNMT1
provides protection of the duplex DNA
from being cut by the restriction enzyme,
and therefore the sustained electrochem-
ical signal directly reports on DNMT1
methylation activity (Figure 1B).
This modular multiplexed electrode
system reveals distinctly increased
DNMT1 methylation activity in cell ex-
tracts from tumor cells relative to that of
tumor-adjacent normal cells. Because
this altered activity precedes the resulting
changes in methylation patterns on
genomic DNA, this method holds much
promise for early detection of precancer-
ous transformations. Moreover, this
strategy may be adapted to create ver-
sions of this platform that report on the
activity of a variety of DNA binding pro-
teins and enzymes implicated in epige-
netics and cancer. As one potential
example, the approach used here for
DNMT1 activity could be modified to
detect faulty removal of aberrant DNA ba-
ses by base excision repair glycosylases
that have been linked to mutagenesis
and carcinogenesis (David et al., 2007).
Indeed, we can envision diagnostic arrays
of such electrode assemblies where each
is tailored to respond to a specific onco-
genic activity such as hypermethylation
or aberrant DNA repair, allowing clinicians
to visualize initial pre-malignant stages of
Figure 1. DNA Charge Transport Based Sensor for Measuring Levels of DNA Methylation
(A) The DNA ‘‘wire’’ is notmethylated in the presence of normal cell extracts, leaving it susceptible to cleav-
age by the restriction enzyme (BssHII), which eliminates the electrochemical current.
(B) DNA methylation by tumor cell extracts protects the DNA ‘‘wire’’ and maintains the electrochemical
signal (represented by the lit bulb).
Chemistry & Biology
Previewscarcinogenesis and providing more effec-
tive opportunities for early intervention. In
summary, Furst and Barton demonstrate
a robust yet sensitive electrochemicalassay that surpasses currently applied
diagnostic methods and that strongly cor-
relates enzymatic activity of DNMT1 to
tumorigenesis.Chemistry & Biology 22, July 23, 2015REFERENCES
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